News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,598 Results
Type
Article (89707)
Company Profile (667)
Press Release (808199)
Multimedia
Podcasts (285)
Webinars (44)
Section
Business (267531)
Career Advice (4177)
Deals (40169)
Drug Delivery (247)
Drug Development (92167)
Employer Resources (212)
FDA (18748)
Job Trends (17566)
News (399667)
Policy (40038)
Tag
2025 Best Places to Work (26)
2026 Best Places to Work (40)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (5)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3113)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (238)
Alliances (57001)
ALS (293)
Alzheimer's disease (2170)
Antibody-drug conjugate (ADC) (786)
Approvals (19351)
Artificial intelligence (1153)
ASCO (350)
Autoimmune disease (542)
Automation (86)
Bankruptcy (414)
Belgium (47)
Best Places to Work (12636)
BIO (84)
Biologics (124)
Biomarkers (1)
BIOSECURE Act (23)
Biosimilars (309)
BioSpace Insights (272)
Biotechnology (340)
Bispecific (65)
Bladder cancer (253)
Brain cancer (105)
Breast cancer (987)
Cancer (8125)
Cardiovascular disease (689)
Career advice (3640)
Career pathing (65)
CAR-T (466)
CDC (82)
CDMO (241)
Celiac Disease (9)
Cell-line development (2)
Cell therapy (1287)
Cervical cancer (69)
Clinical research (81313)
Collaboration (2912)
Commercialization (77)
Company closure (10)
Compensation (1952)
Complete response letters (129)
COVID-19 (3089)
CRISPR (155)
CRO (10)
C-suite (1722)
Cystic fibrosis (183)
Data (11254)
Decentralized trials (4)
Denatured (113)
Depression (230)
Dermatology (210)
Diabetes (856)
Diagnostics (7959)
Digital health (88)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (570)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (390)
Earnings (104836)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (142090)
Executive appointments (1387)
Eye disease (28)
FDA (23909)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2400)
Gene editing (323)
Generative AI (116)
Gene therapy (997)
GLP-1 (1420)
Government (5638)
Grass and pollen (8)
Guidances (446)
Healthcare (21536)
Hematology (241)
HIV (128)
Huntington's disease (94)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (434)
Immuno-oncology (168)
Indications (303)
Infectious disease (3551)
Inflammatory bowel disease (286)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (393)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2883)
JPM (73)
Kidney cancer (32)
Kidney disease (184)
Labor market (154)
Layoffs (734)
Leadership (70)
Legal (10180)
Licensing (142)
Liver cancer (121)
Longevity (58)
Lung cancer (1119)
Lung diease (29)
Lymphoma (572)
Machine learning (78)
Management (72)
Manufacturing (1674)
Marketing (43)
MASH (261)
Medical affairs (6)
Medical device (15491)
Medtech (15832)
Melanoma (255)
Mergers & acquisitions (23661)
Metabolic disorders (2183)
Middle East (2)
mRNA (348)
Multiple sclerosis (264)
Multispecific (7)
NASH (24)
Netherlands (44)
Neurodegenerative disease (643)
Neuropsychiatric disorders (155)
Neuroscience (4399)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (103)
Obesity (1032)
Opinion (411)
Ovarian cancer (303)
Pain (357)
Pancreatic cancer (467)
Parkinson's disease (497)
Partnered (54)
Patents (822)
Patient advocacy (9)
Patient recruitment (989)
Patient selection (125)
Peanut (81)
People (69199)
Peptides (47)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25082)
Phase 2 (35325)
Phase 3 (26624)
Pipeline (14831)
Policy (435)
Postmarket research (3561)
Preclinical (11221)
Press Release (74)
Prostate cancer (415)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (452)
Rare diseases (1625)
Real estate (7479)
Recruiting (84)
Regenerative medicine (40)
Regulatory (31955)
Reports (104)
Research institute (2824)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (411)
Series B (287)
Series C (1)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4409)
State (2)
Stem cells (8)
Stomach cancer (25)
Substance use disorders (23)
Supply chain (175)
Switzerland (26)
Tariffs (109)
Tax incentives (2)
The Weekly (169)
Vaccines (1459)
Venture capital (188)
Weight loss (686)
Wet AMD (8)
Women's health (191)
Women in leadership (2)
Worklife (28)
Date
Today (1)
Last 7 days (765)
Last 30 days (3860)
Last 365 days (33871)
2026 (31228)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51333)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1311)
Alabama (118)
Alaska (7)
Arizona (495)
Arkansas (17)
Asia (53234)
Australia (9379)
California (17452)
Canada (4805)
China (2079)
Colorado (776)
Connecticut (780)
Delaware (550)
Europe (122922)
Florida (2647)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1507)
India (158)
Indiana (788)
Iowa (37)
Japan (791)
Kansas (161)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2058)
Massachusetts (12630)
Michigan (477)
Minnesota (959)
Mississippi (8)
Missouri (192)
Montana (38)
Nebraska (31)
Nevada (209)
New Hampshire (94)
New Jersey (4627)
New Mexico (38)
New York (4548)
North Carolina (2258)
North Dakota (14)
Northern California (8915)
Ohio (545)
Oklahoma (32)
Oregon (55)
Pennsylvania (3346)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6961)
Tennessee (293)
Texas (2903)
United States (61869)
Utah (531)
Vermont (2)
Virginia (437)
Washington D.C. (90)
Washington State (1391)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
There are 898,598 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Capricor’s regulatory odyssey for DMD cell therapy hits second FDA rejection
A new proposed indication was not enough to get deramiocel across the regulatory finish line. The FDA has again turned away the cell therapy, which is being developed for Duchenne muscular dystrophy, for the second time in as many years.
November 21, 2026
·
4 min read
·
Heather McKenzie
Events
[LIVE Webinar] Beyond Affinity: SPR-Guided Antibody Discovery, Engineering, and Characterization of Conjugated Therapeutics
What can SPR reveal beyond binding affinity? Join WuXi Biologics’ live webinar to explore how SPR supports antibody discovery, engineering, and lead optimization. Learn how binding kinetics, blocking assays, and epitope binning inform lead selection; how SPR guides affinity maturation, humanization, and pH-dependent engineering; and how FcγR/FcRn binding analysis supports Fc engineering. Discover SPR strategies for bispecific antibodies and antibody conjugates. Register today!
November 20, 2026
AlloTera Therapeutics
Press Releases
Biomedic Innovative Solutions Introduces New Website Connecting Healthcare Providers with the Latest Regenerative Care Solutions
New digital presence brings the company’s product portfolio and provider support resources together at biomedic.com
November 20, 2026
·
1 min read
Events
The Next Frontier: Personalized LNP Therapeutics for Individual Patients
The Next Frontier: Personalized LNP Therapeutics for Individual Patients
November 20, 2026
Press Releases
Telo Genomics Corp. Announces Non-Brokered Private Placement of Secured Convertible Debentures
November 20, 2026
·
3 min read
Veranex
FDA
FDA will miss rare decision deadline for Savara candidate after three-month delay
Savara shares dropped 18% on the news, though analysts remain confident in approval, instead pointing to potential “bandwidth issues” at the FDA.
November 20, 2026
·
2 min read
·
Gabrielle Masson
Layoff Tracker
As part of sales reorganization, Novo will cut 215 employees at US HQ
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 20, 2026
·
135 min read
·
BioSpace Editorial Staff
Pancreatic cancer
RevMed pads Rasonque’s first-line survival advantage in pancreatic cancer with early data
The new data could help boost Revolution Medicines beyond the currently estimated $14.5 billion in peak sales for the recently approved RAS(ON) inhibitor, Truist Securities predicts.
November 20, 2026
·
3 min read
·
Annalee Armstrong
1 of 89,860
Next